Breaking: New Jersey-based company introduces breakthrough Aireshield technology that transforms standard HVAC systems into molecular-level pathogen elimination systems using confined plasma fields
In a groundbreaking development that could fundamentally reshape indoor air quality standards, Reviveaire has introduced the industry’s first commercial non-thermal plasma-based HVAC air disinfection and filtration product. The Aireshield disinfection module represents a quantum leap in air purification technology, utilizing confined plasma fields to neutralize airborne pathogens at the molecular level while seamlessly retrofitting into existing HVAC systems.
The Aireshield employs a confined and controlled high-voltage plasma field to neutralize airborne pathogens and biological entities as they pass through the HVAC system. This revolutionary approach addresses growing concerns about airborne disease transmission while meeting increasingly stringent indoor air quality standards established by organizations like ASHRAE.
Table of Contents
Revolutionary Plasma Technology: Breaking Down the Science
Non-Thermal Plasma Fundamentals
Reviveaire Aireshield technology harnesses the transformative power of plasma to deliver advanced air filtration. By utilizing a high-voltage electric field of 5500 volts, this innovative system generates plasma that ionizes gas molecules, creating a mix of charged particles.
Unlike thermal plasma systems that require extreme temperatures, non-thermal plasma operates at near-ambient temperatures while maintaining highly reactive ionic conditions. This breakthrough enables safe integration with standard HVAC equipment without thermal stress or system modifications.
Molecular-Level Pathogen Inactivation
Designed to neutralize airborne pathogens at the molecular level, Aireshield® uses a safe, confined plasma field to inactivate viruses, bacteria, mold spores, allergens, and micro-particulates. The plasma field creates reactive oxygen species and charged particles that disrupt pathogen cell walls and genetic material, rendering them inactive without producing harmful byproducts.
Key Inactivation Mechanisms:
- Oxidative Stress: Reactive oxygen species overwhelm pathogen defense mechanisms
- Membrane Disruption: Charged particles break down cellular membranes
- DNA/RNA Damage: High-energy interactions destroy genetic material
- Protein Denaturation: Plasma reactions alter critical protein structures
Technical Specifications and Performance Metrics
Power Efficiency Leadership
The Aireshield uses less than 12 watts of power to create a non-thermal, non-emitting, confined plasma field. This exceptional efficiency represents a paradigm shift from traditional UV-C systems that typically consume 50-200 watts while providing inferior pathogen elimination performance.
Detailed Power Consumption by Model:
ModelDimensionsPower ConsumptionCurrent DrawAS-2424-124"×24"×1"2.741W0.062AAS-2025-125"×20"×1"2.38W0.054AAS-2020-120"×20"×1"1.904W0.043AAS-1625-125"×16"×1"1.904W0.043AAS-1224-124"×12"×1"1.371W0.031A
Enhanced Filtration Performance
Increases the effective MERV rating of post filters through the process of PM particle agglomeration. A post-MERV 8 rated air filter performs like a MERV 13 filter. This enhancement addresses a critical challenge in HVAC system design where high-efficiency filters create excessive pressure drops and energy penalties.
Agglomeration Process Benefits:
- Particle Clustering: Plasma charges cause fine particles to cluster into larger, more filterable units
- Enhanced Capture: Standard filters capture agglomerated particles more effectively
- Reduced Pressure Drop: Higher effective filtration without increased airflow resistance
- Energy Savings: Lower fan energy consumption compared to high-MERV filters
Comprehensive Pathogen Elimination
Reviveaire’s air modules are lab-certified for the elimination of various viruses, mold, and bacteria. Independent testing validates the technology’s effectiveness against a broad spectrum of airborne pathogens including coronaviruses, influenza, and respiratory syncytial virus.
Product Configuration and Installation Flexibility
Standard Model Lineup
The Aireshield module comes in various standard filter sizes, for an easy retrofit into existing HVAC systems. The comprehensive size range ensures compatibility with most commercial and residential HVAC applications without system modifications.
Standard Configurations:
- AS-2424-1: 24″×24″×1″ for large residential and small commercial systems
- AS-2025-1: 25″×20″×1″ for medium commercial applications
- AS-2020-1: 20″×20″×1″ for standard residential systems
- AS-1625-1: 25″×16″×1″ for compact commercial installations
- AS-1224-1: 24″×12″×1″ for specialized applications
Custom Sizing Capabilities
For special sizes and applications, we can customize the size of the Aireshield module to fit your HVAC system’s needs. This customization capability addresses unique installation requirements in specialized facilities like laboratories, healthcare settings, and industrial applications.
Universal Installation Compatibility
The Aireshield can be installed at any location in the air handlers’ airflow, from the air return inlet or any air outlet. This flexibility enables optimal positioning for maximum pathogen exposure time while accommodating space constraints and maintenance accessibility requirements.
Installation Advantages:
- No Ductwork Modifications: Direct replacement for standard filter slots
- Standard Electrical Connection: 110-220V compatibility with existing HVAC power
- Continuous Operation: Functions during cooling, heating, and ventilation modes
- Minimal Maintenance: Long-life design reduces service requirements
Market Applications and Industry Impact
Healthcare Facility Integration
The healthcare market represents a primary target for Aireshield technology, where airborne pathogen control directly impacts patient safety and infection control protocols. Aireshield is a system designed to combat indoor airborne pathogens while adhering to ASHRAE’s 241 standards.
Healthcare Applications:
- Patient Rooms: Continuous pathogen elimination protecting vulnerable populations
- Operating Theaters: Enhanced air quality supporting surgical sterility requirements
- Waiting Areas: Reduced cross-contamination in high-occupancy spaces
- Long-Term Care: Protection for elderly residents at elevated risk
Commercial and Educational Markets
Our filters disinfect the air in your home, effectively eliminating airborne contaminants and dramatically reducing the risk of infections from diseases like COVID-19 and the flu. While this statement references residential applications, the technology’s effectiveness translates directly to commercial environments with similar pathogen challenges.
Commercial Applications:
- Office Buildings: Improved workplace safety and reduced sick leave
- Schools and Universities: Healthier learning environments with fewer outbreaks
- Retail Spaces: Enhanced customer and employee protection
- Transportation Hubs: Pathogen control in high-traffic environments
Residential Market Penetration
Aireshield retrofits effortlessly into any existing HVAC unit, transforming it into a full-home air disinfection system for continuous protection. The residential market offers substantial growth potential as homeowners increasingly prioritize indoor air quality following pandemic awareness.
Competitive Advantages and Market Differentiation
Energy Efficiency Leadership
Traditional UV-C systems require substantial energy consumption and frequent lamp replacement, creating ongoing operational costs. The Aireshield’s minimal power consumption and long service life provide compelling total cost of ownership advantages.
Efficiency Comparisons:
- UV-C Systems: 50-200W continuous operation plus lamp replacement costs
- Aireshield Technology: Under 3W operation with minimal maintenance requirements
- HEPA Systems: High pressure drops requiring increased fan energy
- Plasma Technology: Enhanced filtration without airflow resistance
Safety and Ozone Considerations
By safely stepping up standard 120/240-volt systems to 5,500 volts, Aireshield generates a powerful, ozone-free plasma field, ensuring cleaner, air without harmful byproducts. This ozone-free operation addresses regulatory concerns and indoor air quality standards.
Safety Features:
- Confined Plasma Field: High-voltage operation within enclosed, shielded module
- Ozone-Free Design: No harmful byproduct generation during operation
- Standard Voltage Integration: Safe electrical connection to existing HVAC systems
- UL Listed Components: Compliance with electrical safety standards
Performance Sustainability
The Aireshield, over ten years, will pay for itself in energy savings multiple times over the initial cost. This long-term economic value proposition addresses facility management concerns about ROI and lifecycle costs.
Technology Development and Future Enhancements
Planned 2025 Developments
Future non-thermal plasma based variations planned for a 2nd Qtr. 2025 include an app to connect with building management systems to monitor/control filter operation and maintenance. This connectivity enhancement positions the technology for smart building integration and predictive maintenance capabilities.
Smart Integration Features:
- BMS Connectivity: Integration with existing building automation systems
- Real-Time Monitoring: Continuous performance tracking and analytics
- Predictive Maintenance: Algorithm-based service scheduling
- Remote Diagnostics: Cloud-based troubleshooting and optimization
Standalone Unit Development
Another planned addition for 2025 is a standalone non-thermal plasma-based unit for rooms under 2,800 cu. ft. This development expands market reach into smaller spaces that lack central HVAC systems or require supplemental air treatment.
Standalone Applications:
- Individual Offices: Personal workspace protection without HVAC integration
- Hotel Rooms: Portable pathogen control for hospitality industry
- Small Retail: Independent air quality enhancement for boutique spaces
- Residential Rooms: Targeted treatment for bedrooms or home offices
Scientific Validation and Testing Protocols
Independent Laboratory Testing
The Aireshield technology has undergone rigorous third-party testing to validate pathogen elimination claims. Testing protocols follow established standards for microbial reduction and air purification effectiveness.
Testing Parameters:
- Viral Inactivation: SARS-CoV-2, influenza, and common respiratory viruses
- Bacterial Elimination: Staphylococcus, Streptococcus, and other common bacteria
- Mold Spore Control: Aspergillus, Penicillium, and other fungal contaminants
- Particle Reduction: PM2.5 and ultrafine particulate matter capture
Regulatory Compliance and Certification
The technology meets or exceeds current indoor air quality standards while maintaining compliance with electrical and safety regulations. Ongoing certification efforts address emerging standards and international markets.
Economic Analysis and Market Implications
Total Cost of Ownership Benefits
The Aireshield’s economic proposition extends beyond initial equipment costs to encompass long-term operational savings and health-related benefits.
Cost Components:
- Initial Investment: Competitive with high-end filtration systems
- Energy Savings: Minimal power consumption reduces operating costs
- Maintenance Reduction: Long service life minimizes replacement frequency
- Health Benefits: Reduced sick leave and medical costs for facility occupants
Market Sizing and Growth Potential
The global air purification market continues expanding, driven by increased health awareness and regulatory requirements. The HVAC integration approach addresses the largest segment of the air treatment market.
Market Segments:
- Healthcare: $2.8 billion annual market with growing pathogen control focus
- Commercial Buildings: $4.1 billion market emphasizing energy efficiency
- Residential: $1.9 billion market with increasing IAQ awareness
- Industrial: $1.2 billion market requiring specialized air treatment
Installation and Service Considerations
Contractor Training and Support
Successful market adoption requires comprehensive training programs for HVAC contractors and service technicians. The technology’s electrical components necessitate proper installation and maintenance procedures.
Training Components:
- Electrical Safety: High-voltage system safety protocols and procedures
- Installation Techniques: Proper positioning and electrical connections
- Performance Verification: Testing procedures to confirm proper operation
- Troubleshooting: Diagnostic techniques for system maintenance
Warranty and Service Support
Comprehensive warranty programs provide customer confidence while establishing service networks for ongoing support. The technology’s reliability reduces service requirements compared to traditional systems.
Industry Response and Competitive Dynamics
Traditional Technology Challenges
Existing air purification technologies face limitations that plasma technology addresses:
UV-C Limitations:
- High energy consumption and heat generation
- Lamp replacement requirements and mercury disposal
- Limited effectiveness against certain pathogens
- Potential ozone generation concerns
HEPA Filter Challenges:
- High pressure drops increasing energy consumption
- Limited pathogen inactivation capabilities
- Frequent replacement requirements
- Space and installation constraints
Market Adoption Timeline
Commercial adoption of new HVAC technologies typically requires 2-3 years for widespread acceptance. Early adopters include healthcare facilities and premium commercial buildings prioritizing indoor air quality.
Adoption Phases:
- Year 1: Healthcare and high-risk facility installation
- Year 2: Premium commercial building integration
- Year 3: Mainstream commercial and residential adoption
- Year 4+: Standard inclusion in new HVAC system designs
Future Technology Evolution and Industry Impact
Plasma Technology Advancement
Continued development of non-thermal plasma technology may enable enhanced performance and reduced costs. Research focuses on optimizing plasma generation efficiency and expanding pathogen elimination capabilities.
Integration with Smart Building Systems
The planned BMS connectivity positions the technology for integration with comprehensive building management strategies including demand-controlled ventilation and energy optimization.
Regulatory Influence and Standards Development
Successful deployment of plasma technology may influence future indoor air quality standards and building code requirements. Organizations like ASHRAE continue evaluating emerging technologies for standard incorporation.
Global Market Expansion and International Opportunities
International Market Penetration
The technology’s universal HVAC compatibility enables global market expansion with minimal product modifications. International building standards increasingly emphasize indoor air quality and pathogen control.
Target Markets:
- European Union: Strict indoor air quality regulations and energy efficiency focus
- Asia-Pacific: Rapid commercial construction and air quality concerns
- Middle East: Healthcare facility expansion and extreme climate challenges
- Latin America: Growing commercial market and health infrastructure development
Manufacturing and Distribution Strategy
Successful global expansion requires strategic manufacturing partnerships and distribution networks. The technology’s relatively simple manufacturing requirements support distributed production strategies.
Conclusion: Transforming HVAC Industry Standards
Reviveaire’s introduction of non-thermal plasma technology represents a watershed moment for the HVAC industry, offering a solution that simultaneously addresses pathogen control, energy efficiency, and system integration challenges. The Aireshield disinfection module not only cleans the air but revitalizes it. Our advanced disinfection technology effectively removes harmful constituents, allergens, and particles (PM2.5), creating a healthier indoor environment for living and working.
The technology’s ability to retrofit into existing systems while providing superior performance at minimal energy consumption addresses key market needs that traditional solutions have struggled to meet effectively. As building owners and facility managers increasingly prioritize indoor air quality, the Aireshield platform provides a comprehensive solution that delivers measurable results without system disruption.
The planned enhancements including smart building integration and standalone units position the technology for sustained growth across multiple market segments. With healthcare facilities leading adoption and commercial buildings following, the plasma-based approach may establish new industry standards for air disinfection and purification.
For HVACR professionals, the Aireshield technology represents both an opportunity and a challenge—opportunity to provide clients with cutting-edge air quality solutions, and challenge to understand and properly implement advanced plasma technology. Success in this emerging market will require commitment to training and technical expertise that matches the sophistication of the technology.
As the HVACR industry continues evolving toward more efficient and effective indoor air quality solutions, Reviveaire’s plasma technology demonstrates that breakthrough innovations can emerge from focused research and development efforts. The technology’s success will likely inspire continued innovation across the air purification market while establishing plasma-based systems as viable alternatives to traditional approaches.